Acumen Pharmaceuticals, Inc. (ABOS) vs Cardiol Therapeutics Inc. (CRDL)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and Cardiol Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CRDL
Cardiol Therapeutics Inc.
$1.32HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ABOS vs CRDL
growth of $100 · dividends reinvested · last 5yABOS -89.4% (-36.2%/yr)CRDL -44.4% (-11.1%/yr)CRDL compounded faster over this window
Log scale — wide-divergence pair
ABOS CRDL
ABOS vs CRDL: by the numbers
- •ABOS is the larger company ($154M vs $152M market cap).
Metrics side by side
Valuation
| Metric | ABOS | CRDL |
|---|---|---|
| P/B ratio | 2.69 | 8.99 |
Profitability
| Metric | ABOS | CRDL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -183.44% | -155.34% |
| ROIC | -118.67% | -165.56% |
Growth (annualized)
| Metric | ABOS | CRDL |
|---|---|---|
| Total return CAGR (5Y) | -32.60% | -18.36% |
Frequently asked
- How have ABOS and CRDL total returns compared?
- Over the past 5 years, ABOS delivered -32.60% and CRDL delivered -18.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.